title: Too much AKT turns PAX3-FKHR dead: a prospect of novel therapeutic strategy for alveolar rhabdomyosarcoma.
authors.forename: Mathivanan
authors.initials: M
authors.lastname: Jothi
authors.forename: Asoke K
authors.initials: AK
authors.lastname: Mal
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002454:Cell Differentiation; D004195:Disease Models, Animal; D006801:Humans; D015514:Oncogene Proteins, Fusion / Q000037:antagonists & inhibitors*; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D018232:Rhabdomyosarcoma, Alveolar / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D015514:Oncogene Proteins, Fusion; C523321:PAX3-FKHR fusion protein, human; C577105:PAX3-FKHR fusion protein, mouse; D051057:Proto-Oncogene Proteins c-akt